During the past decade, Altman Clinical and Translational Research Institute conducted 55 clinical trials. In the 10-year time frame, 55 clinical trials started and 14 clinical trials were completed, i.e. on average, 25.5% percent of trials that started reached the finish line to date. In the past 5 years, 40 clinical trials started and 12 clinical trials were completed. i.e. 30% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Altman Clinical and Translational Research Institute" #1 sponsor was "University of California, San Diego" with 27 trials, followed by "COMPASS Pathways" with 3 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored, "Pfizer" with 3 trials sponsored and "Aardvark Therapeutics, Inc." with 3 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Altman Clinical and Translational Research Institute" #1 collaborator was "Salk Institute for Biological Studies" with 4 trials as a collaborator, "Juvenile Diabetes Research Foundation" with 3 trials as a collaborator, "REMD Biotherapeutics, Inc." with 3 trials as a collaborator, "University of California, San Diego" with 3 trials as a collaborator and "Prothena Biosciences Limited" with 2 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "Altman Clinical and Translational Research Institute" are "Obstructive Sleep Apnea" (4 trials), "Anorexia Nervosa" (3 trials), "Depression" (3 trials), "Obesity" (3 trials) and "Sleep" (3 trials). Many other conditions were trialed in "Altman Clinical and Translational Research Institute" in a lesser frequency.

Most popular intervention types in "Altman Clinical and Translational Research Institute" are "Drug" (43 trials), "Behavioral" (10 trials), "Device" (6 trials), "Other" (5 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "REMD-477" (4 trials), "Psilocybin" (3 trials), "Standard of Care" (3 trials) and "ARD-101" (2 trials). Other intervention names were less common.

The vast majority of trials in "Altman Clinical and Translational Research Institute" are 60 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are 34 active trials in "Altman Clinical and Translational Research Institute". 2 are not yet recruiting, 20 are recruiting, 11 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 27 completed trials in Altman Clinical and Translational Research Institute, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Altman Clinical and Translational Research Institute, 7 "Phase 1" clinical trials were conducted, 25 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 14 trials that are defined as “Not Applicable".